
Richard George Everson MD FAANS, FACS (He/Him)
Brain & Spinal Tumor, Pituitary Surgery, Skull Base
Assistant Professor, Neurosurgery, UCLA School of Medicine
Join to view full profile
Wasserman Building300 Stein Plaza, Suite 420Los Angeles, CA 90095
Phone+1 310-825-5111
Fax+1 310-825-5111
Dr. Everson is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Everson has expertise in the surgical treatment of primary and metastatic tumors of the brain, spine and skull base. He works with multidisciplinary oncology teams to individualize patient treatments. Dr. Everson employs the full range of minimally invasive, image-guided, endoscopic, radiosurgery, microsurgical, conventional open and reconstructive techniques to ensure both maximum tumor removal and patient safety. His research focuses on immunotherapy and clinical trials for brain tumors.
Education & Training
University of Texas M D Anderson Cancer CenterFellowship, Neurosurgical Oncology, 2016 - 2017
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Neurological Surgery, 2009 - 2016
Duke University School of MedicineClass of 2009
University of Michigan Medical SchoolBS, Cellular and Molecular Biology, 2005
Certifications & Licensure
CA State Medical License 2011 - 2027
NV State Medical License 2023 - 2027
TX State Medical License 2016 - 2027
American Board of Neurological Surgery Neurological Surgery
Awards, Honors, & Recognition
- Brian D. Silber Award (AANS) 2017
- California Association of Neurological Surgeons Best Abstract Award 2016
- UCLA Neurosurgery Resident Award for Academic Excellence 2013
Publications & Presentations
PubMed
- 2 citationsFocused Ultrasound in Brain Tumors: Mechanisms, Imaging Guidance, and Emerging Clinical Applications.Ali Nabavizadeh, Kazim Narsinh, Timothy J Kaufmann, HaoLi Liu, Antonios N Pouliopoulos
AJNR. American Journal of Neuroradiology. 2026-06-03 - Effect of Anti-Siphon Devices on Postoperative Outcomes in Idiopathic Normal Pressure Hydrocephalus.Yashaar Hafizka, Sheel Shah, Jorge Salcedo-Sifuentes, Sheantel Reihl, Kunal Patel
World Neurosurgery. 2026-06-01 - Laser Interstitial Thermal Therapy for Brain Metastases: Imaging Guidelines for Clinical Trials and Practice.Francesco Sanvito, Aden P Haskell-Mendoza, Eric C Leuthardt, Albert H Kim, Jingwen Yao
Neuro-Oncology. 2026-05-29
Journal Articles
- Chiari I Malformation in the AdultEverson, RG, Holly, LT, and Batzdorf, U, Neurosurgery Quarterly, 1/1/2015
Books/Book Chapters
Abstracts/Posters
- Laser Thermotherapy for Spinal Metastatic Disease provides Comparable Local Control, Reduced Morbidity and Delay to Systemic Therapy Compared to Open SurgeryEverson RG, Feranandes B, Zuckerman S, Rao G, Li J, Ghia A, Amini B, Rhines, L, Tatsui CE, 85th American Association of Neurological Surgeons Annual Meeting, 1/1/2017
- Outcomes of Surgery for Sacral Chordoma and Impact of Complications: A Report of 50 Consecutive Patients with Long-term Follow-upZuckerman S, Chang G, Walsh G, Mehran R, Everson R, Lee S, Rao G, Tatsui C, Rhines L, The Congress of Neurological Surgeons Spine Summit 2017 - 33rd Annual Meeting of the Section on Disorders of the Spine and Peripheral Nerves, 1/1/2017
- Interbody distraction and vertebral body reconstruction with PMMA for the treatment of pathologic fracturesZuckerman S, Everson R, Rao G, McCutcheon I, Rhines L, Tatsui C, The Congress of Neurological Surgeons Spine Summit 2017 - 33rd Annual Meeting of the Section on Disorders of the Spine and Peripheral Nerves, 1/1/2017
Lectures
- Laser Thermotherapy for Spinal Metastatic Disease provides Comparable Local Control, Reduced Morbidity and Less Delay to Systemic Therapy Compared to Open SurgeryLos Angeles, CA - 1/1/2017
- Emerging Approaches in Brain Tumor ImmunotherapyLos Angeles, CA - 1/1/2017
- PD-1 Inhibition Enhances Dendritic Cell Vaccine-Generated Anti-Tumor Immune Response against GlioblastomaPismo Beach, CA - 1/1/2016
Press Mentions
Adding Immune-Boosting Agent to Personalised Cancer Vaccine Supercharges the Body's Immune Defense Against Malignant Brain TumoursMay 10th, 2024
New Technique Gives a Clearer Image of Immunotherapy Results in Advanced Brain CancerSeptember 5th, 2017
UCLA Researchers Help Lead National Effort to Improve Care for Patients with GlioblastomaMay 8th, 2026
Grant Support
- Understanding the role of tumor microenvironment in low grade glioma progression to malignancyCALIFORNIA INSTITUTE OF TECHNOLOGY2024–2029
Professional Memberships
- Member
- Member
- Society for Neuro-OncologyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









